Showing results (331-340 of 371) with videos related to

Sort By:
Pageof 38
The Lancet. Oncology|February 3, 2022
Therapeutic avenues for cancer neuroscience: translational frontiers and clinical opportunitiesDiana D Shi, Jimmy A Guo, Hannah I Hoffman, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2025
Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813: A Phase III Study of Radiation and Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic AstrocytomaJessica L Fleming, Stephanie L Pugh, Susan M Chang, et al.
The Lancet. Oncology|November 27, 2025
Neurocognitive outcomes in patients with brain metastases: a systematic reviewTarek Bou Dargham, Sebastian F Winter, Kristen Batich, et al.
World Neurosurgery|October 13, 2019
Atypical Histopathological Features and the Risk of Treatment Failure in Nonmalignant Meningiomas: A Multi-Institutional AnalysisNayan Lamba, William L Hwang, Daniel W Kim, et al.
Practical Radiation Oncology|July 6, 2024
A Case-based Guide for World Health Organization (WHO) Grade 2 Meningioma Radiosurgery and Radiation Therapy from The Radiosurgery SocietyApril K Vassantachart, Felix Ehret, Eric Chen, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2016
Practice Patterns Analysis of Ocular Proton Therapy Centers: The International OPTIC SurveyJan Hrbacek, Kavita K Mishra, Andrzej Kacperek, et al.
Advances in Radiation Oncology|June 14, 2017
Analysis of patient outcomes following proton radiation therapy for retinoblastomaKent W Mouw, Beow Y Yeap, Paul Caruso, et al.
Neuro-Oncology|November 11, 2017
A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913Prakash Chinnaiyan, Minhee Won, Patrick Y Wen, et al.
Neuro-Oncology|January 25, 2026
Cognitive Function, Quality of Life, and Survival Outcomes in Patients with Lower Grade Gliomas Treated with Proton Radiation Therapy: A Phase II studyJason M Slater, Nora K Horick, Lisa B Nachtigall, et al.
Journal of Neuro-Oncology|March 7, 2013
The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancerPaul W Sperduto, Norbert Kased, David Roberge, et al.
Pageof 38